logo

Crowdly

Browser

Add to Chrome

Researchers are developing a CRISPR–Cas9 therapy to correct a pathogenic point ...

✅ The verified answer to this question is available below. Our community-reviewed solutions help you understand the material better.

Researchers are developing a CRISPR–Cas9 therapy to correct

a pathogenic point mutation in a gene responsible for an inherited blood

disorder. During preclinical testing, several unintended genomic regions are

also cleaved, raising concerns about off-target effects. The research team

decides to redesign part of the CRISPR system to improve targeting precision.

Which component of the CRISPR–Cas9 system would most

directly need to be modified to improve DNA targeting specificity, and why?

More questions like this

Want instant access to all verified answers on learning.monash.edu?

Get Unlimited Answers To Exam Questions - Install Crowdly Extension Now!

Browser

Add to Chrome